Bao Haipeng, Si Dongxu, Gao Longxia, Sun Huizhuo, Shi Qi, Yan Yue, Damchaaperenlei Dashzeveg, Li Chunlei, Yu MingXia, Li Youlin
Beijing University of Chinese Medicine.
The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital.
Medicine (Baltimore). 2018 Dec;97(51):e13772. doi: 10.1097/MD.0000000000013772.
Allergic rhinitis is a major chronic inflammatory disease of the respiratory tract. A large number of epidemiological investigations have shown that the prevalence of allergic rhinitis (AR) is increasing, resulting in a large burden of disease. Desensitizing drugs such as nasal glucocorticoids and antihistamines are commonly used to treat allergic rhinitis, but this method has a long treatment period and is prone to repeated attacks, and there are certain adverse reactions. Acupuncture can be used to treat a wide variety of diseases including allergic rhinitis without the occurrence of drug damage. We aim to evaluate the efficacy and safety of acupuncture in the treatment of allergic rhinitis.
Relevant databases include the English databases incorporating Web of science, PubMed, Springer, Medline, Cochrane Library, EBASE, WHO International Clinical Trials Registry Platform (ICTRP), as well as the Chinese databases like the China National Knowledge Infrastructure Database (CNKI), Chinese Scientific Journal Database (VIP), Wanfang Database, and Chinese Biomedical Literature Database will be searched normatively according to the rule of each database from the inception to September 1, 2018. Reference list of identified studies, potential gray literatures, relevant conference abstracts, and clinical trial registrations will also be searched. The literature screening, data extraction, and quality assessment will be conducted by 2 researchers independently. Data will be synthesized by either the fixed-effects or random-effects model according to a heterogeneity test. Symptom score will be assessed as the primary outcome. Rhinoconjunctivitis quality of life questionnaire (RQLQ), participants with asthma can use asthma control test (ACT), medicine usage and scoring, laboratory examination, and side effects or adverse events will be evaluated as the secondary outcome. Meta-analysis will be performed using RevMan5.3.5 software provided by the Cochrane Collaboration.
This study will provide high-quality synthesis based on current evidence of acupuncture treatment for allergic rhinitis in several aspects, including symptom score, drug score, quality of life score, asthma control score, side effects and laboratory examination such as nasal function test, serum total immunoglobulin (IgE), nasal secretion smear, etc. CONCLUSION:: The results of this study will provide updated evidence for weather acupuncture is an effective and safe intervention for allergic rhinitis.
It is not necessary for this systematic review to acquire an ethical approval. This review will be disseminated in a peer-reviewed journal or conference presentation.
PROSPERO CRD42018109105.
变应性鼻炎是一种主要的呼吸道慢性炎症性疾病。大量流行病学调查显示,变应性鼻炎(AR)的患病率正在上升,导致了巨大的疾病负担。鼻用糖皮质激素和抗组胺药等脱敏药物常用于治疗变应性鼻炎,但这种方法治疗周期长,且易反复发作,还存在一定的不良反应。针刺可用于治疗包括变应性鼻炎在内的多种疾病,且不会出现药物损害。我们旨在评估针刺治疗变应性鼻炎的疗效和安全性。
相关数据库包括英文数据库如科学网、PubMed、Springer、Medline、Cochrane图书馆、EBASE、世界卫生组织国际临床试验注册平台(ICTRP),以及中文数据库如中国知网数据库(CNKI)、中文科技期刊数据库(VIP)、万方数据库和中国生物医学文献数据库,将根据各数据库的规则从建库至2018年9月1日进行规范检索。还将检索已识别研究的参考文献列表、潜在的灰色文献、相关会议摘要和临床试验注册信息。文献筛选、数据提取和质量评估将由2名研究人员独立进行。根据异质性检验,数据将采用固定效应模型或随机效应模型进行合并。症状评分将作为主要结局进行评估。鼻结膜炎生活质量问卷(RQLQ),哮喘患者可使用哮喘控制测试(ACT),药物使用及评分、实验室检查以及副作用或不良事件将作为次要结局进行评估。将使用Cochrane协作网提供的RevMan5.3.5软件进行Meta分析。
本研究将基于目前针刺治疗变应性鼻炎的证据,在症状评分、药物评分、生活质量评分、哮喘控制评分、副作用以及实验室检查如鼻功能测试、血清总免疫球蛋白(IgE)、鼻分泌物涂片等多个方面提供高质量的综合分析。结论:本研究结果将为针刺是否是变应性鼻炎的有效和安全干预措施提供最新证据。
本系统评价无需获得伦理批准。本评价将在同行评审期刊或会议报告中发表。
PROSPERO注册号:PROSPERO CRD42018109105。